ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

LY4167586

A development code.

Its studies are mostly in Obesity, led by Eli Lilly.

Furthest: phase 1, since Oct 20, 20252 company-led studies, 2 open or runningNext primary completion: Dec 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Eli Lilly22 open or runningphase 1since Oct 20, 2025Oct 20, 2025Dec 2026phase 1 · NCT07225556

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 20, 2025First study: phase 1 study in OverweightFirst studyNCT07225556 · 84 enrolled · United States, Singapore
  2. Oct 13, 2026Phase 1 study in ObesityNCT07881887 · 617 planned · United States, Singapore

Ahead

  1. Dec 2026Primary completion: phase 1 study in OverweightNCT07225556
  2. Mar 2029Primary completion: phase 1 study in ObesityNCT07881887

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07881887Obesity · United States, Singapore1RecruitingMar 2029617
NCT07225556Overweight · United States, Singapore1Active, not recruitingDec 202684

How it is read

Names in the registry

  • “LY4167586”, 3 entries

Codes read as this program: LY4167586.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.